Fairness in cost-benefit analysis: A methodology for health technology assessment - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Health Economics Année : 2018

Fairness in cost-benefit analysis: A methodology for health technology assessment

Résumé

We evaluate the introduction of various forms of antihypertensive treatments in France with a distribution-sensitive cost-benefit analysis. Compared to traditional cost-benefit analysis, we implement distributional weighting based on equivalent incomes, a new concept of individual well-being that does respect individual preferences but is not subjectively welfarist. Individual preferences are estimated on the basis of a contingent valuation question, introduced into a representative survey of the French population. Compared to traditional cost-effectiveness analysis in health technology assessment, we show that it is feasible to go beyond a narrow evaluation of health outcomes while still fully exploiting the sophistication of medical information. Sensitivity analysis illustrates the relevancy of this richer welfare framework, the importance of the distinction between an ex ante and an ex post approach, and the need to consider distributional effects in a broader institutional setting.
Fichier non déposé

Dates et versions

hal-02302587 , version 1 (01-10-2019)

Identifiants

Citer

Anne-Laure Samson, Erik Schokkaert, Clémence Thebaut, Brigitte Dormont, Marc Fleurbaey, et al.. Fairness in cost-benefit analysis: A methodology for health technology assessment. Health Economics, 2018, 27 (1), pp.102 - 114. ⟨10.1002/hec.3515⟩. ⟨hal-02302587⟩
85 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More